Swiss pharma giant Novartis (NOVN: VX) has announced plans to expand its operations in North Carolina, USA, creating a new ...

The US-China Economic and Security Review Commission has presented its 2025 annual report to Congress in the USA.

US biotech Dewpoint Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Fast Track ...

Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has approved a new ...

Cambridge, USA-based mRNA vaccines company Moderna today announced the expansion of its US manufacturing capabilities with ...

A new industry-supported study released for World AMR Awareness Week highlights widening gaps between falling antibiotic ...

Xiangxue Life Sciences has agreed a strategic partnership with Guangzhou-based Damien Vaccines to co-develop in vivo TCR-T ...

Specialty pharma company SERB Pharmaceuticals has revealed the appointment of Vignesh Rajah as its chief medical officer (CMO ...

US pharma major Merck (NYSE: MRK) has reported positive topline data from the Phase II Cadence trial, testing Winrevair ...

The landscape of phosphodiesterase 3/4 (PDE3/4) inhibitors is experiencing a significant transformation in 2025, driven by ...

US RNA interference (RNAi)specialist Arrowhead Pharmaceuticals, yesterday revealed that the US Food and Drug Administration ...

Bayer (BAYN: DE) has opened its first China-based innovation center in Beijing’s E-Town BioPark, positioning the site as a launchpad for local biotechs aiming for global markets. The German pharma ...